PDI Combing Urology, Neurology Markets For Licensing/Acquisition Deals
PDI is aiming to build a "long-term portfolio" of specialty products through licensing deals, beginning in the urology and neurology markets
You may also be interested in...
PDI's breach of contract settlement with Auxilium is a result of the contract sales organization's new strategy of competing with small pharmaceutical manufacturers
PDI will focus on smaller contract sales opportunities in the 50-representative range following termination of the Evista promotion deal with Lilly, CEO Charles Saldarini said on a conference call Nov. 12
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011